Achieve Life Sciences, Inc. SEC filings ACHV
Achieve Life Sciences, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Apr 15, 2009. Its latest annual report, Form ARS, was filed on Jun 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 1, 2026 | Oct 1, 2026 |
| 8-K |
Current report
Other events
|
Aug 14, 2026 | Aug 14, 2026 |
| 424B5 | Prospectus supplement | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jul 6, 2026 | Jul 2, 2026 |
| ARS | Annual report to shareholders | Jun 8, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Jun 8, 2026 | Jun 8, 2026 |
| 8-K |
Current report
Officer or director change
|
Jun 2, 2026 | May 29, 2026 |
| PRE 14A | Preliminary proxy statement | May 29, 2026 | May 29, 2026 |
| EFFECT | Filing | May 21, 2026 | — |
| CORRESP | Letter to the SEC | May 19, 2026 | — |
| UPLOAD | Letter from the SEC | May 18, 2026 | — |
| S-8 | Employee stock plan registration | May 12, 2026 | — |
| S-3 | Shelf registration | May 12, 2026 | — |
| 10-Q | Quarterly report | May 12, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
May 12, 2026 | May 7, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Apr 16, 2026 | Apr 15, 2026 |
| S-8 | Employee stock plan registration | Apr 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 24, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 24, 2026 | Mar 24, 2026 |
| EFFECT | Filing | Jan 29, 2026 | — |
| CORRESP | Letter to the SEC | Jan 27, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 27, 2026 | — |
| S-3 | Shelf registration | Jan 23, 2026 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2025 | Oct 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 11, 2025 | Sep 5, 2025 |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 27, 2025 | Jun 26, 2025 |
| 424B5 | Prospectus supplement | Jun 27, 2025 | — |
| 424B5 | Prospectus supplement | Jun 26, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2025 | Jun 4, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 28, 2025 | Apr 28, 2025 |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 8-K |
Current report
Other events
|
Feb 10, 2025 | Feb 10, 2025 |
| S-8 | Employee stock plan registration | Jan 10, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 10, 2025 | Jan 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2024 | Dec 5, 2024 |
| S-8 | Employee stock plan registration | Dec 5, 2024 | — |
| EFFECT | Filing | Nov 18, 2024 | — |
| EFFECT | Filing | Nov 14, 2024 | — |
| CORRESP | Letter to the SEC | Nov 14, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 14, 2024 | — |
| S-3 | Shelf registration | Nov 7, 2024 | — |
| POS AM | Filing | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2024 | Sep 27, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Aug 26, 2024 | Aug 20, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2024 | Aug 13, 2024 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Jul 29, 2024 | Jul 25, 2024 |
| EFFECT | Filing | Jul 8, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 3, 2024 | — |
| CORRESP | Letter to the SEC | Jul 3, 2024 | — |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 6, 2024 | Jun 5, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | May 6, 2024 | — |
| CORRESP | Letter to the SEC | May 2, 2024 | — |
| UPLOAD | Letter from the SEC | May 2, 2024 | — |
| S-3 | Shelf registration | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, Unregistered share sale, Regulation FD disclosure
|
Feb 29, 2024 | Feb 28, 2024 |
| 424B5 | Prospectus supplement | Feb 29, 2024 | — |
| 8-K |
Current report
Other events
|
Dec 11, 2023 | Dec 11, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2023 | Aug 14, 2023 |
| EFFECT | Filing | Jun 23, 2023 | — |
| CORRESP | Letter to the SEC | Jun 21, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 20, 2023 | — |
| S-3 | Shelf registration | Jun 14, 2023 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2023 | Jun 7, 2023 |
| 424B5 | Prospectus supplement | May 25, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
May 25, 2023 | May 25, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 23, 2023 | May 23, 2023 |
| 8-K |
Current report
Material agreement, New debt
|
May 17, 2023 | May 15, 2023 |
| 10-K/A | Amended annual report | May 16, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | May 9, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 3, 2023 | Apr 28, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 7, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 30, 2023 | Mar 29, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 23, 2023 | Mar 21, 2023 |
| S-8 | Employee stock plan registration | Mar 16, 2023 | — |
| 10-K | Annual report | Mar 16, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Material agreement
|
Mar 6, 2023 | Mar 1, 2023 |
| 424B7 | Filing | Jan 12, 2023 | — |
| EFFECT | Filing | Jan 11, 2023 | — |
| CORRESP | Letter to the SEC | Jan 5, 2023 | — |
| UPLOAD | Letter from the SEC | Jan 4, 2023 | — |
| S-3/A | Filing | Jan 3, 2023 | — |
| DEL AM | Filing | Dec 30, 2022 | — |
| S-3 | Shelf registration | Dec 29, 2022 | — |
| D/A | Filing | Dec 8, 2022 | — |
| D | Filing | Nov 29, 2022 | — |
| 8-K |
Current report
Listing notice
|
Nov 25, 2022 | Nov 22, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Nov 18, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Nov 14, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2022 | Nov 14, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 1, 2022 | May 31, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Apr 27, 2022 | Apr 26, 2022 |
| DEF 14A | Proxy statement | Apr 21, 2022 | May 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2022 | Mar 8, 2022 |
| S-8 | Employee stock plan registration | Mar 10, 2022 | — |
| 10-K | Annual report | Mar 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| EFFECT | Filing | Jan 5, 2022 | — |
| CORRESP | Letter to the SEC | Jan 3, 2022 | — |
| CORRESP | Letter to the SEC | Dec 30, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 28, 2021 | — |
| DEL AM | Filing | Dec 22, 2021 | — |
| 8-K |
Current report
Material agreement, New debt
|
Dec 22, 2021 | Dec 22, 2021 |
| S-3 | Shelf registration | Dec 21, 2021 | — |
| 10-Q | Quarterly report | Nov 9, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, Other events
|
May 25, 2021 | May 25, 2021 |
| 424B5 | Prospectus supplement | May 25, 2021 | — |
| 424B5 | Prospectus supplement | May 24, 2021 | — |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
May 13, 2021 | May 13, 2021 |
| DEF 14A | Proxy statement | Mar 30, 2021 | May 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2021 | Mar 9, 2021 |
| S-8 | Employee stock plan registration | Mar 11, 2021 | — |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2021 | Mar 11, 2021 |
| 424B4 | Prospectus | Dec 4, 2020 | — |
| EFFECT | Filing | Dec 2, 2020 | — |
| S-1MEF | Filing | Dec 2, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| FWP | Free writing prospectus | Nov 30, 2020 | — |
| S-1/A | Amended registration statement | Nov 30, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 18, 2020 | — |
| S-1 | Registration statement | Nov 13, 2020 | — |
| 10-Q | Quarterly report | Nov 12, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2020 | Oct 22, 2020 |
| 8-K |
Current report
Agreement ended
|
Oct 21, 2020 | Oct 20, 2020 |
| 8-K |
Current report
Officer or director change
|
Sep 30, 2020 | Sep 28, 2020 |
| 8-K |
Current report
Other events
|
Aug 20, 2020 | Aug 14, 2020 |
| 10-Q | Quarterly report | Aug 6, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2020 | Aug 6, 2020 |
| 8-K |
Current report
Material agreement
|
Aug 4, 2020 | Aug 3, 2020 |
| 424B5 | Prospectus supplement | Aug 4, 2020 | — |
| 424B5 | Prospectus supplement | Aug 3, 2020 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jul 30, 2020 | Jul 29, 2020 |
| 424B5 | Prospectus supplement | Jun 29, 2020 | — |
| 8-K |
Current report
Material agreement
|
Jun 29, 2020 | Jun 29, 2020 |
| EFFECT | Filing | Jun 16, 2020 | — |
| CORRESP | Letter to the SEC | Jun 12, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 11, 2020 | — |
| S-1 | Registration statement | Jun 5, 2020 | — |
| S-8 | Employee stock plan registration | May 19, 2020 | — |
| 10-Q | Quarterly report | May 14, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
May 14, 2020 | May 14, 2020 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Apr 30, 2020 | Apr 27, 2020 |
| UPLOAD | Letter from the SEC | Apr 2, 2020 | — |
| DEF 14A | Proxy statement | Apr 2, 2020 | May 12, 2020 |
| PRER14A | Filing | Mar 30, 2020 | — |
| PRE 14A | Preliminary proxy statement | Mar 19, 2020 | May 12, 2020 |
| 10-K | Annual report | Mar 13, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2020 | Mar 13, 2020 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2020 | Jan 24, 2020 |
| S-8 | Employee stock plan registration | Jan 24, 2020 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 20, 2019 | Dec 17, 2019 |
| 424B4 | Prospectus | Dec 18, 2019 | — |
| EFFECT | Filing | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 17, 2019 | — |
| CORRESP | Letter to the SEC | Dec 16, 2019 | — |
| CORRESP | Letter to the SEC | Dec 16, 2019 | — |
| CORRESP | Letter to the SEC | Dec 16, 2019 | — |
| S-1/A | Amended registration statement | Dec 16, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- In Vitro & In Vivo Diagnostic Substances (SIC 2835)
- Listed as
- ACHV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 949858
- Former names
- ONCOGENEX PHARMACEUTICALS, INC. (until Jul 31, 2017); SONUS PHARMACEUTICALS INC (until Aug 7, 2008)
Other In Vitro & In Vivo Diagnostic Substances companies
- Idexx Laboratories Inc /DE IDXX
- Lantheus Holdings, Inc. LNTH
- Neogen Corp NEOG
- Celldex Therapeutics, Inc. CLDX
- Intellia Therapeutics, Inc. NTLA
- QuidelOrtho Corp QDEL
- Myriad Genetics Inc MYGN
- Alpha Teknova, Inc. TKNO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.